CVE-2025-0893: Symantec Diagnostic Tool · Improper Privilege Management
Affects Symantec Diagnostic ToolSource CVE Database V5
Not known to be exploited · CVSS 7.8 High.
Data as of 4 Nov 2026, 00:43 UTC
Thin evidence
One scorer or none| CNA (symantec) | CVSS 3.1 | 7.8 |
|---|
- EPSS
- 0.1% chance of exploitation in 30 days – higher than 4% of CVEsExploit Prediction Scoring System: the likelihood attackers will use this flaw soon.
- CISA SSVC
- Exploitation
- No evidence of active exploitation and no public proof of concept
- Automatable
- Attackers cannot reliably automate steps 1–4 of the kill chain
- Technical impact
- Total control over the software or total information disclosure
CISA SSVC assessment, 2025-02-27.
CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:HExploitation evidence
Disclosed: evidence found.
CVE published 19 Feb 2025
Detectable: no evidence on record.
No public nuclei template indexed
Weaponized: no evidence on record.
No public exploit code indexed in Metasploit or Exploit-DB
Exploited in the wildExploited: no evidence on record.
Not in CISA KEV and no source reports exploitation
Observed by OffSeq MirageSeen by Mirage: no evidence on record.
No attack traffic recorded by OffSeq Mirage sensors
A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), the Metasploit, Exploit-DB and nuclei-templates index as of 3 Nov 2026.
What to do
Affected software
| Product | Affected | Fixed in |
|---|---|---|
| SymantecSymantec Diagnostic Tool | Affected
| Fixed in– |
AI-suggested
Until a fix is available, restrict access to the Symantec Diagnostic Tool and limit user privileges to reduce the risk of exploitation.
Description
Symantec Diagnostic Tool (SymDiag), prior to 3.0.79, may be susceptible to a Privilege Escalation vulnerability.